About this Webinar
In this webinar Sakis Paliouras, Ph.D., Managing Oncology Analyst at GlobalData, will present an overview of the IO market landscape, drawing on key insights from GlobalData’s recently published report, Thematic Research: Immuno-Oncology. The most important current treatment options and most promising pipeline drugs for IO will be covered, including a discussion on GlobalData’s sales forecasts for the total IO market globally. The webinar will cover insights from various key opinion leaders (KOLs) on the current treatment options, pipeline drugs, unmet needs, and the most promising R&D strategies. Other topics covered include key regulatory information, as well as market access issues and concern for IO.
Speakers
Sakis Paliouras
Sakis Paliouras, PhD, is a Managing Oncology and Hematology Analyst at GlobalData in New York. He specializes in data-driven business intelligence in the oncology pharmaceutical market particularly in blood malignancies, in the field of immuno-oncology, and using quantitative approaches for data analysis. Sakis produces and manages syndicated reports directly and is experienced in helping clients in both syndicated and consulting projects. Before joining GlobalData, Sakis graduated with a BSc in Molecular Biology and Genetics from the Democritus University of Thrace (DUTH). He greatly enjoys coding and has also run a small freelancing business. He then received a Cancer Research UK-funded PhD in Cancer Medicine from the Cancer Research UK Manchester Institute, University of Manchester. His research focused on the identification of mechanisms of resistance to targeted therapies in lung cancer. Sakis is passionate about biomarker-driven development in oncology as well as therapies with novel mechanisms of action
Past Webinars
View more past webinarsUpcoming Webinars
View more upcoming webinarsSearch companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer


